| Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study … G Coltro, AA Mangaonkar, TL Lasho, CM Finke, P Pophali, R Carr, ... Leukemia 34 (5), 1407-1421, 2020 | 82 | 2020 |
| Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients T Coston, P Pophali, R Vallapureddy, TL Lasho, CM Finke, RP Ketterling, ... American journal of hematology 94 (7), 767-779, 2019 | 64 | 2019 |
| Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt … AA Mangaonkar, DM Swoboda, G Coltro, TL Lasho, PJ Novotny, ... Leukemia 34 (2), 656-661, 2020 | 43 | 2020 |
| Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia P Pophali, A Matin, AA Mangaonkar, R Carr, M Binder, A Al-Kali, ... Blood cancer journal 10 (11), 121, 2020 | 27 | 2020 |
| Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia PA Pophali, MM Timm, AA Mangaonkar, M Shi, K Reichard, A Tefferi, ... Blood cancer journal 9 (9), 65, 2019 | 21 | 2019 |
| Left gonadal vein thrombosis in a patient with COVID-19-associated coagulopathy M Veyseh, P Pophali, A Jayarangaiah, A Kumar BMJ Case Reports CP 13 (9), e236786, 2020 | 20 | 2020 |
| Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation MM Patnaik, PA Pophali, TL Lasho, CM Finke, P Horna, RP Ketterling, ... Haematologica 104 (6), e236, 2019 | 20 | 2019 |
| Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients P Pophali, P Horna, TL Lasho, CM Finke, RP Ketterling, N Gangat, ... American journal of hematology 93 (11), 1347-1357, 2018 | 13 | 2018 |
| Incidental asymptomatic splenic infarct in a COVID-19 patient N Ghalib, P Pophali, N Chamorro-Pareja, A Jayarangaiah, A Kumar Cureus 13 (2), 2021 | 7 | 2021 |
| Increased mortality among smokers with myelodysplastic syndrome (MDS). PD Zavras, P Pophali, A Shastri, L Bachier-Rodriguez, AR Sica, ... Journal of Clinical Oncology 39 (15_suppl), e19036-e19036, 2021 | 1 | 2021 |
| CAR‐T cell therapy J Franklin, P Pophali, Z Jackson, D Wald, D Avigan Molecular Hematology, 369-396, 2024 | | 2024 |
| Immune checkpoint blockade in hematological malignancies: current state and future potential P Pophali, JC Varela, J Rosenblatt Frontiers in Oncology 14, 2024 | | 2024 |
| Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents P Pophali, SR Desai, A Shastri Current Hematologic Malignancy Reports 18 (3), 56-67, 2023 | | 2023 |
| Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: INCREASED MORTALITY AMONG SMOKERS WITH MYELODYSPLASTIC SYNDROMES (MDS) P Zavras, P Pophali, L Bachier-Rodriguez, R Sica, M Goldfinger, ... Leukemia Research 108, 106681.2, 2021 | | 2021 |
| Chronic giardiasis: a rare cause of exocrine pancreatic insufficiency P Pophali, M Veyseh, O Fraij, S Hapangama BMJ Case Reports CP 14 (5), e242129, 2021 | | 2021 |
| Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations P Pophali, TL Lasho, C Finke, P Horna, RP Ketterling, N Gangat, ... Blood 132, 3100, 2018 | | 2018 |
